Aurinia Pharmaceuticals, Inc. (AUPH)
15.80
+0.14
(+0.89%)
USD |
NASDAQ |
Jun 09, 16:00
15.80
0.00 (0.00%)
After-Hours: 18:49
Aurinia Pharmaceuticals Total Liabilities (Quarterly) : 156.37M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| enGene Therapeutics, Inc. | 55.57M |
| Medicus Pharma Ltd. | 4.299M |
| Kiniksa Pharmaceuticals International Plc | 219.59M |
| Xenon Pharmaceuticals, Inc. | 48.99M |
| Psyence Biomedical Ltd. | -- |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 724.00M |
| Shareholders Equity (Quarterly) | 567.63M |
| Debt to Equity Ratio | 0.1209 |
| Current Ratio | 5.548 |
| Net Debt Paydown Yield | 0.11% |